Mahlon R. DeLong
Mahlon R. DeLong publishes mostly in Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience, on topics such as Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments and Genetic Neurodegenerative Diseases.
- World rank
- #19,271 of 7,710,434 ranked researchers
- Rank in United States
- #6,985 of 1,627,098
- Works
- 220
- Citations
- 55k
- Citations per work
- 248.3
What does Mahlon R. DeLong research?
Mahlon R. DeLong's work is mostly in Medicine (53%), Neuroscience (31%), Biochemistry, Genetics and Molecular Biology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences11753.0%
- Medicine11753.0%
- Life Sciences7433.6%
- Everything else2913.4%
- 1Neurology50% of their works
- 2Cellular and Molecular Neuroscience18% of their works
- 3Cognitive Neuroscience9% of their works
- 4Neurology5% of their works
- 5Endocrinology, Diabetes and Metabolism3% of their works
- 6Molecular Biology2% of their works
Research topics
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Genetic Neurodegenerative Diseases
- Botulinum Toxin and Related Neurological Disorders
- Neuroscience and Neuropharmacology Research
- Transcranial Magnetic Stimulation Studies
- Neurological and metabolic disorders
- Parkinson's Disease and Spinal Disorders
Which keywords describe Mahlon R. DeLong's research?
The keywords of their largest research topics: Parkinson's Disease, Neurological Disorders, Mitochondrial Dysfunction, Basal Ganglia, Deep Brain Stimulation, Subthalamic Nucleus, Treatment-Resistant Depression and a-Synuclein.
- Hyperglycemia
- Chorea
- Transcranial Magnetic Stimulation
- Synaptic Plasticity
- Neurotoxins
- Stroke
- Huntington's Disease
- Neurodegeneration
- Subthalamic Nucleus
- Basal Ganglia
- Neurological Disorders
- Parkinson's Disease
- Mitochondrial Dysfunction
- Deep Brain Stimulation
- Treatment-Resistant Depression
- a-Synuclein
- Protein Aggregation
- Botulinum Toxin
- Neurotransmission
- Transcranial Direct Current Stimulation
- Camptocormia
- Dropped Head Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Parkinson's Disease2633 topics
- Neurological Disorders2164 topics
- Mitochondrial Dysfunction1662 topics
- Basal Ganglia1602 topics
- Deep Brain Stimulation1602 topics
- Subthalamic Nucleus1461 topic
- Treatment-Resistant Depression1461 topic
- Neurodegeneration1031 topic
- a-Synuclein1031 topic
- Huntington's Disease631 topic
- Protein Aggregation631 topic
- Stroke442 topics
- Botulinum Toxin301 topic
- Neurotoxins301 topic
- Neurotransmission261 topic
- Synaptic Plasticity261 topic
- Transcranial Direct Current Stimulation221 topic
- Transcranial Magnetic Stimulation221 topic
- Camptocormia141 topic
- Chorea141 topic
- Dropped Head Syndrome141 topic
- Hyperglycemia141 topic
Where does Mahlon R. DeLong work?
Mahlon R. DeLong's main affiliation in the publication record is Emory University, United States.
How many publications and citations does Mahlon R. DeLong have?
OpenAlex counts 220 works and 54,625 citations for Mahlon R. DeLong, an h-index of 90, ranking #19,271 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mahlon R. DeLong. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.